The role of lymphovascular space invasion in renal cell carcinoma as a prognostic marker of survival after curative resection

Urologic Oncology: Seminars and Original Investigations

Volumn 29, Issue 6, 2011, Pages 738-744

  Katz, Matthew D ^a   Serrano, Maria F ^a   Humphrey, Peter A ^a   Grubb, Robert L ^a,b   Skolarus, Ted A ^a   Gao, Feng ^a   Kibel, Adam S ^a,b  

^a WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b USA   (United States)

Author keywords

Kidney cancer; Lymphovascular invasion; Nephrectomy; Survival

Indexed keywords

ADULT; AGED; ARTICLE; CANCER INVASION; CANCER STAGING; CANCER SURGERY; CANCER SURVIVAL; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; HUMAN; KIDNEY CARCINOMA; LYMPH VESSEL INVASION; MAJOR CLINICAL STUDY; MALE; METASTASIS; OVERALL SURVIVAL; PARTIAL NEPHRECTOMY; PATHOLOGIST; PRIORITY JOURNAL; PROGNOSIS; TUMOR VOLUME;

AGED; CARCINOMA, RENAL CELL; HUMANS; KAPLAN-MEIER ESTIMATE; KIDNEY NEOPLASMS; LYMPHATIC METASTASIS; MIDDLE AGED; NEOPLASM GRADING; NEOPLASM STAGING; PROGNOSIS; PROPORTIONAL HAZARDS MODELS;

EID: 81055124332     PISSN: 10781439     EISSN: 18732496     Source Type: Journal    
DOI: 10.1016/j.urolonc.2009.07.034     Document Type: Article

References (28)

1. Jemal A., Siegel R., Ward E., et al. Cancer Statistics, 2009. CA Cancer J Clin 2009, 59:225-249.
2. Janzen N.K., Kim H.L., Figlin R.A., et al. Surveillance after radical or partial nephrectomy for localized renal cell carcinoma and management of recurrent disease. Urol Clin North Am 2003, 30:843-852.
3. Campbell S.C., Novick A.C., Bukowski R.M. Renal Tumors. Campbell-Walsh Urology 2007, 1567-1637. W. B. Saunders, Philadelphia. 9th ed. A.J. Wein, L.R. Kavoussi, A.C. Novick (Eds.).
4. Bukowski R.M. Natural history and therapy of metastatic renal cell carcinoma: The role of interleukin-2. Cancer 1997, 80:1198-1220.
5. Amin M.B., Amin M.B., Tamboli P., et al. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: An experience of 405 cases. Am J Surg Pathol 2002, 26:281-291.
6. Bretheau D., Lechevallier E., de Fromont M., et al. Prognostic value of nuclear grade in renal cell carcinoma. Cancer 1995, 76:2543-2549.
7. Gokden N., Nappi O., Swanson P.E., et al. Renal cell carcinoma with rhabdoid features. Am J Surg Pathol 2000, 24:1329-1338.
8. Cheville J.C., Lohse C.M., Zincke H., et al. Comparisons of outcome and prognostic features among histologic subtypes of renal cell carcinoma. Am J Surg Pathol 2003, 27:612-624.
9. Lin W., Hu F., Chung S., et al. The role of lymphovascular invasion in predicting the prognosis of clinically localized upper tract urothelial carcinoma (pT1-3cNOMO). J Urol 2008, 180:879-884.
10. Heidenreich A., Sesterhenn I., Mostofi F., et al. Prognostic risk factors that identify patients with clinical stage I nonseminomatous germ cell tumors at low risk and high risk for metastasis. Cancer 1998, 83:1002-1011.
11. Lotan Y., Gupta A., Shariat S., et al. Lymphovascular invasion is independently associated with overall survival, cause-specific survival, and local and distant recurrence in patients with negative lymph nodes at radical cystectomy. J Clin Oncol 2005, 23:6533-6539.
12. Dall'Oglio M., Antunes A., Sarkis A., et al. Microvascular tumor invasion in renal cell carcinoma: The most important prognostic factor. BJU Int 2007, 100:552-555.
13. Dall'Oglio M., Filho L., Antunes A., et al. Microvascular tumor invasion, tumor size, and Fuhrman grade: A pathological triad for prognostic evaluation of renal cell carcinoma. J Urol 2007, 178:425-428.
14. Madbouly K., Al-Qahtani S., Ghazwani Y., et al. Microvascular tumor invasion: Prognostic significance in low-stage renal cell carcinoma. Urology 2007, 69:670-674.
15. Dall'Oglio M., Arap M., Antunes A., et al. Impact of clinicopathological parameters in patients treated for renal cell carcinoma. J Urol 2007, 177:1687-1691.
16. Goncalves P., Srougi M., Dall'Oglio M., et al. Low clinical stage renal cell carcinoma: Relevance of microvascular tumor invasion as a prognostic parameter. J Urol 2004, 172:470-474.
17. Yildiz E., Gokce G., Kilicarslan H., et al. Prognostic value of the expression of Ki-67, CD44, and vascular endothelial growth factor, and microvessel invasion, in renal cell carcinoma. BJU Int 2004, 93:1087-1093.
18. Lang H., Lindner V., Letourneux H., et al. Prognostic value of microscopic venous invasion in renal cell carcinoma: Long-term follow-up. Eur Urol 2004, 46:331-335.
19. Griffiths D., Verghese A., Golash A., et al. Contribution of grade, vascular invasion, and age to outcome in clinically localized renal cell carcinoma. BJU Int 2002, 90:26-31.
20. Dekel Y., Koren R., Kugel V., et al. Significance of angiogenesis and microvascular invasion in renal cell carcinoma. Pathol Oncol Res 2002, 8:129-132.
21. Van Poppel H., Vandendriessche H., Boel K., et al. Microscopic vascular invasion is the most relevant prognosticator after radical nephrectomy for clinically nonmetastatic renal cell carcinoma. J Urol 1997, 158:45-49.
22. Yildiz E., Ayan S., Goze F., et al. Relation of microvessel density with microvascular invasion, metastasis, and prognosis in renal cell carcinoma. BJU Int 2007, 101:758-764.
23. Horiguchi A., Keiichi I., Sumitomo M., et al. Intratumoral lymphatics and lymphatic invasion are associated with tumor aggressiveness and poor prognosis in renal cell carcinoma. Urology 2008, 71:928-932.
24. Ishimura T., Sakai I., Hara I., et al. Microscopic venous invasion in renal cell carcinoma as a predictor of recurrence after radical surgery. Int J Urol 2004, 11:264-268.
25. Ishimura T., Sakai I., Harada K., et al. Clinicopathological features of recurrence after radical surgery for nonmetastatic renal cell carcinoma. Int J Clin Oncol 2004, 9:369-372.
26. Sevinc M., Kirkali Z., Yorukoglu K., et al. Prognostic significance of microvascular invasion in localized renal cell carcinoma. Eur Urol 2000, 38:728-733.
27. Lang H., Lindner V., Saussine C., et al. Microscopic venous invasion: A prognostic factor in renal cell carcinoma. Eur Urol 2000, 38:600-605.
28. Sorbellini M., Kattan M., Snyder M., et al. A postoperative prognostic nomogram predicting recurrence for patients with conventional clear cell carcinoma. J Urol 2005, 173:48-51.